Table of Contents
International Journal of Proteomics
Volume 2014, Article ID 129064, 14 pages
http://dx.doi.org/10.1155/2014/129064
Research Article

Prediction of Spontaneous Regression of Cervical Intraepithelial Neoplasia Lesions Grades 2 and 3 by Proteomic Analysis

1Norconsult AS, Section 355 QA Service, P.O. Box 216, NO-4503 Mandal, Norway
2Former International Research Institute of Stavanger (IRIS), P.O. Box 8046, 4068 Stavanger, Norway
3Pathology Department, Stavanger University Hospital, P.O. Box 8100, 4068 Stavanger, Norway
4Department of Gynecology and Obstetrics, Stavanger University Hospital, P.O. Box 8100, 4068 Stavanger, Norway
5Department of Medical Biochemistry, Stavanger University Hospital, P.O. Box 8100, 4068 Stavanger, Norway
6Mediteam AS, Sjøveien 34, 4315 Sandnes, Norway
7The Gade Institute, University of Bergen, P.O. Box 1400, 5021 Bergen, Norway

Received 30 January 2014; Revised 29 April 2014; Accepted 14 May 2014; Published 15 June 2014

Academic Editor: Jen-Fu Chiu

Copyright © 2014 Kai-Erik Uleberg et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. H. zur Hausen, “Papillomaviruses in the causation of human cancers—a brief historical account,” Virology, vol. 384, no. 2, pp. 260–265, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. R. P. Insinga, E. J. Dasbach, and E. H. Elbasha, “Epidemiologic natural history and clinical management of human papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model,” BMC Infectious Diseases, vol. 9, article 119, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. J. P. Baak, A. J. Kruse, S. J. Robboy, E. A. Janssen, B. van Diermen, and I. Skaland, “Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers,” Journal of Clinical Pathology, vol. 59, no. 10, pp. 1017–1028, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. A. C. Munk, A. J. Kruse, B. van Diermen et al., “Cervical intraepithelial neoplasia grade 3 lesions can regress,” APMIS, vol. 115, no. 12, pp. 1409–1414, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. M. R. McCredie, C. Paul, K. J. Sharples et al., “Consequences in women of participating in a study of the natural history of cervical intraepithelial neoplasia 3,” Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 50, no. 4, pp. 363–370, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. A. G. Ostor, “Natural history of cervical intraepithelial neoplasia—a critical review,” International Journal of Gynecological Pathology, vol. 12, no. 2, pp. 186–192, 1993. View at Google Scholar · View at Scopus
  8. P. P. Martin-Hirsch, E. Paraskevaidis, A. Bryant, H. O. Dickinson, and S. L. Keep, “Surgery for cervical intraepithelial neoplasia,” Cochrane Database of Systematic Reviews, vol. 16, no. 6, Article ID CD001318, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Kyrgiou, G. Koliopoulos, P. Martin-Hirsch, M. Arbyn, W. Prendiville, and E. Paraskevaidis, “Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis,” The Lancet, vol. 367, no. 9509, pp. 489–498, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Sadler, A. Saftlas, W. Wang, M. Exeter, J. Whittaker, and L. McCowan, “Treatment for cervical intraepithelial neoplasia and risk of preterm delivery,” The Journal of the American Medical Association, vol. 291, no. 17, pp. 2100–2106, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. A. S. Kadish, P. Timmins, Y. Wang et al., “Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide,” Cancer Epidemiology Biomarkers and Prevention, vol. 11, no. 5, pp. 483–488, 2002. View at Google Scholar · View at Scopus
  12. A. C. Munk, E. Gudlaugsson, I. T. Ovestad et al., “Interaction of epithelial biomarkers, local immune response and condom use in cervical intraepithelial neoplasia 2-3 regression,” Gynecologic Oncology, vol. 127, no. 3, pp. 489–494, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. I. T. Ovestad, E. Gudlaugsson, I. Skaland et al., “The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2-3,” Journal of Clinical Pathology, vol. 64, no. 4, pp. 303–307, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. I. T. Ovestad, E. Gudlaugsson, I. Skaland et al., “Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression,” Modern Pathology, vol. 23, no. 9, pp. 1231–1240, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. A. J. Kruse, I. Skaland, E. A. Janssen et al., “Quantitative molecular parameters to identify low-risk and high-risk early CIN lesions: role of markers of proliferative activity and differentiation and Rb availability,” International Journal of Gynecological Pathology, vol. 23, no. 2, pp. 100–109, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. J. P. Baak and A. J. Kruse, “Use of biomarkers in the evaluation of CIN grade and progression of early CIN,” Methods in Molecular Medicine, vol. 119, pp. 85–99, 2005. View at Google Scholar · View at Scopus
  17. K. E. Uleberg, A. C. Munk, C. Brede et al., “Identification of water soluble proteins recovered from biopsies with high-grade intraepithelial neoplasia,” Journal of Proteomics, vol. 9, no. 36, 2011. View at Google Scholar
  18. K. E. Uleberg, A. C. Munk, C. Brede et al., “Discrimination of grade 2 and 3 cervical intraepithelial neoplasia by means of analysis of water soluble proteins recovered from cervical biopsies,” Proteome Science, vol. 9, article 36, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. E. I. Chen and J. R. Yates III, “Cancer proteomics by quantitative shotgun proteomics,” Molecular Oncology, vol. 1, no. 2, pp. 144–159, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. Quality assurance manual, Norwegian Cancer Registry, National advisory board for the Norwegian cervical cancer screening program, 2012, http://www.kreftregisteret.no/no/Forebyggende/Masseundersokelsen-mot-livmorhalskreft.
  21. K. E. Uleberg, A. C. Munk, I. Skaland et al., “A protein profile study to discriminate CIN lesions from normal cervical epithelium,” Cellular Oncology, vol. 34, no. 5, pp. 443–450, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Zegels, G. A. van Raemdonck, E. P. Coen, W. A. Tjalma, and X. W. M. van Ostade, “Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples,” Proteome Science, vol. 7, article 17, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Rajalahti, A. C. Kroksveen, R. Arneberg et al., “A multivariate approach to reveal biomarker signatures for disease classification: application to mass spectral profiles of cerebrospinal fluid from patients with multiple sclerosis,” Journal of Proteome Research, vol. 9, no. 7, pp. 3608–3620, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Rajalahti, R. Arneberg, A. C. Kroksveen, M. Berle, K. Myhr, and O. M. Kvalheim, “Discriminating variable test and selectivity ratio plot: quantitative tools for interpretation and variable (biomarker) selection in complex spectral or chromatographic profiles,” Analytical Chemistry, vol. 81, no. 7, pp. 2581–2590, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Rajalahti, R. Arneberg, F. S. Berven, K. M. Myhr, R. J. Ulvik, and O. M. Kvalheim, “Biomarker discovery in mass spectral profiles by means of selectivity ratio plot,” Chemometrics and Intelligent Laboratory Systems, vol. 95, no. 1, pp. 35–48, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Urrutia, “KRAB-containing zinc-finger repressor proteins,” Genome Biology, vol. 4, no. 10, article 231, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. J. H. Laity, B. M. Lee, and P. E. Wright, “Zinc finger proteins: new insights into structural and functional diversity,” Current Opinion in Structural Biology, vol. 11, no. 1, pp. 39–46, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Iuchi, “Three classes of C2H2 zinc finger proteins,” Cellular and Molecular Life Sciences, vol. 58, no. 4, pp. 625–635, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. K. J. Brayer and D. J. Segal, “Keep your fingers off my DNA: protein-protein interactions mediated by C2H2 zinc finger domains,” Cell Biochemistry and Biophysics, vol. 50, no. 3, pp. 111–131, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Huang, S. Yang, R. Ge, H. Sun, F. Shen, and Y. Wang, “ZNF23 induces apoptosis in human ovarian cancer cells,” Cancer Letters, vol. 266, no. 2, pp. 135–143, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. He, J. Cai, J. W. Lim, K. Kroll, and L. Ma, “A novel KRAB domain-containing zinc finger transcription factor ZNF431 directly represses Patched1 transcription,” The Journal of Biological Chemistry, vol. 286, no. 9, pp. 7279–7289, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. J. L. Merchant, M. Saqui-Salces, and M. El-Zaatari, “Hedgehog signaling in gastric physiology and cancer,” Progress in Molecular Biology and Translational Science, vol. 96, pp. 133–156, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Zuo and Y. Song, “Detection and analysis of the methylation status of PTCH1 gene involved in the hedgehog signaling pathway in a human gastric cancer cell line,” Experimental and Therapeutic Medicine, vol. 6, no. 6, pp. 1365–1368, 2013. View at Google Scholar
  34. H. Liu, C. Zhu, J. Luo et al., “ZNF411, a novel KRAB-containing zinc-finger protein, suppresses MAP kinase signaling pathway,” Biochemical and Biophysical Research Communications, vol. 320, no. 1, pp. 45–53, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Poehlmann and A. Roessner, “Importance of DNA damage checkpoints in the pathogenesis of human cancers,” Pathology Research and Practice, vol. 206, no. 9, pp. 591–601, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. J. L. Lessard, R. A. Robinson, and H. T. Hoffman, “Differential expression of ras signal transduction mediators in verrucous and squamous cell carcinomas of the upper aerodigestive tract,” Archives of Pathology and Laboratory Medicine, vol. 125, no. 9, pp. 1200–1203, 2001. View at Google Scholar · View at Scopus
  37. K. Mishima, E. Yamada, K. Masui et al., “Overexpression of the ERK/MAP kinases in oral squamous cell carcinoma,” Modern Pathology, vol. 11, no. 9, pp. 886–891, 1998. View at Google Scholar · View at Scopus
  38. M. Branca, M. Ciotti, D. Santini et al., “Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer,” American Journal of Clinical Pathology, vol. 122, no. 6, pp. 902–911, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Ruttkay-Nedecky, A. M. Jimenez Jimenez, L. Nejdl et al., “Relevance of infection with human papillomavirus: the role of the p53 tumor suppressor protein and E6/E7 zinc finger proteins (Review),” International Journal of Oncology, vol. 43, no. 6, pp. 1754–1762, 2013. View at Publisher · View at Google Scholar
  40. T. Mino, T. Mori, Y. Aoyama, and T. Sera, “Gene- and protein-delivered zinc finger-staphylococcal nuclease hybrid for inhibition of DNA replication of human papillomavirus,” PLoS ONE, vol. 8, no. 2, Article ID e56633, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Mino, T. Mori, Y. Aoyama, and T. Sera, “Inhibition of human papillomavirus replication by using artificial zinc-finger nucleases,” Nucleic Acids Symposium Series, no. 52, pp. 185–186, 2008. View at Google Scholar · View at Scopus
  42. J. G. Donaldson, “Phospholipase D in endocytosis and endosomal recycling pathways,” Biochimica et Biophysica Acta—Molecular and Cell Biology of Lipids, vol. 1791, no. 9, pp. 845–849, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. M. G. Roth, “Molecular mechanisms of PLD function in membrane traffic,” Traffic, vol. 9, no. 8, pp. 1233–1239, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. M. McDermott, M. J. Wakelam, and A. J. Morris, “Phospholipase D,” Biochemistry and Cell Biology, vol. 82, no. 1, pp. 225–253, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. D. A. Foster and L. Xu, “Phospholipase D in cell proliferation and cancer,” Molecular Cancer Research, vol. 1, no. 11, pp. 789–800, 2003. View at Google Scholar · View at Scopus
  46. J. J. Ipsaro, A. D. Haase, S. R. Knott, L. Joshua-Tor, and G. J. Hannon, “The structural biochemistry of Zucchini implicates it as a nuclease in piRNA biogenesis,” Nature, vol. 491, no. 7423, pp. 279–283, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Nishimasu, H. Ishizu, K. Saito et al., “Structure and function of Zucchini endoribonuclease in piRNA biogenesis,” Nature, vol. 491, no. 7423, pp. 284–287, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Esposito, S. Magliocca, D. Formicola, and F. Gianfrancesco, “PiR_015520 belongs to Piwi-associated RNAs regulates expression of the human melatonin receptor 1A gene,” PLoS ONE, vol. 6, no. 7, Article ID e22727, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Lin and H. Yin, “A novel epigenetic mechanism in Drosophila somatic cells mediated by PIWI and piRNAs,” Cold Spring Harbor Symposia on Quantitative Biology, vol. 73, pp. 273–281, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. Lu, C. Li, K. Zhang et al., “Identification of piRNAs in Hela cells by massive parallel sequencing,” BMB Reports, vol. 43, no. 9, pp. 635–641, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. V. N. Kim, “Small RNAs just got bigger: piwi-interacting RNAs (piRNAs) in mammalian testes,” Genes and Development, vol. 20, no. 15, pp. 1993–1997, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. H. J. Ferreira, H. Heyn, X. Garcia del Muro et al., “Epigenetic loss of the PIWI/piRNA machinery in human testicular tumorigenesis,” Epigenetics, vol. 9, no. 1, pp. 113–118, 2013. View at Publisher · View at Google Scholar
  53. S. Siddiqi, M. Terry, and I. Matushansky, “Hiwi mediated tumorigenesis is associated with DNA hypermethylation,” PloS ONE, vol. 7, no. 3, Article ID e33711, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. S. K. Swanson and M. P. Washburn, “The continuing evolution of shotgun proteomics,” Drug Discovery Today, vol. 10, no. 10, pp. 719–725, 2005. View at Publisher · View at Google Scholar · View at Scopus